Full-Time
Master Data Specialist
AI-driven precision medicine through clinical and molecular data analysis
Junior, Mid
Chicago, IL, USA
- Bachelor's Degree in supply chain, operations, information systems, data analytics or related field
- 2-3 years experience working in ERP system(s) affected by material master data
- Experience in the use of supply chain or demand planning tools affected by master data
- Ability to work independently and coordinate information from several departments
- Thrives in a fast-paced environment with a sense of urgency
- Impeccable organizational skills and attention to detail
- Flexibility to perform other supply chain related functions as necessary
- Passion for process improvement and documentation
- Be the Material Master Data owner and expert on other supply chain master data
- Create and modify Bills of Material for new and existing laboratory test offerings
- Create and modify Item Master information within ERP system
- Create and modify material specifications to reference within Tempus quality management system(s)
- Continuously audit item information for gaps or errors that may affect internal teams
- Participation in project teams as master data expert
- Lead innovative improvement activities for new master data fields
- Process mass uploads with item changes to ERP system
- Train other departments on material master data related topics
- Liaise with laboratory and quality teams on updated points of use or potential replacement specifications
- Provides data and reporting as needed to key accounts and associations
Tempus Labs, Inc. is a leader in precision medicine, leveraging artificial intelligence to analyze vast clinical and molecular data, enabling physicians to deliver personalized, data-driven care. The company's advanced machine learning platform and unique solution sets facilitate the discovery, development, and delivery of optimized therapeutic options for patients. With a focus on extensive molecular profiling, Tempus has developed a robust pan-cancer tumor organoid platform and validated a liquid biopsy assay, demonstrating their commitment to transforming personalized patient care and their position at the forefront of the healthcare industry.
Company Stage
Series G
Total Funding
$1.3B
Headquarters
Chicago, Illinois
Founded
2015